Skip to main content

Advertisement

Table 2 Clinical response

From: Development of a multiparameter flow cytometric assay as a potential biomarker for homologous recombination deficiency in women with high-grade serous ovarian cancer

Best response HGSOC with gBRCAm HGSOC without gBRCAm Total (N)
Median duration of response (range) Median duration of response (range)
CR 0 0 0
PR 5/5 (100%) 16 months (1017 months) 1/10 (10%) 3 months 6/15 (40%)
SD ≥ 4 months 0/5 3/10 4 months (45 months) 3/15 (20%)
PD 0/5 6/10 (60%) 6/15 (40%)